At ESMN Horizon, we partner with GP practices, private clinics, and research site networks to help them become research-ready, commercially active, and strategically positioned for growth.
Through our Site Growth & Readiness Partnership, we embed the structures, training, and commercial frameworks that enable sites to operate efficiently, attract more studies, and build long-term sustainability.
We meet each site where it is — whether you’re exploring your first study or scaling an established research operation.
Our work begins with a readiness and capability assessment, identifying operational gaps and opportunities for commercial improvement. From there, we tailor a plan that aligns governance, staffing, infrastructure, and business strategy.
Beyond readiness, we deliver business development, sponsor engagement, and advisory support to ensure sites translate capability into revenue and impact.
With over 20 years of experience across clinical research delivery, commercial leadership, and site partnership strategy, ESMN Horizon bridges the gap between capability and commercial success.
We understand both the science and the business of clinical research — empowering sites to grow with confidence, efficiency, and measurable impact.

We help transform compliant research sites into commercially successful operations — ready to attract new studies, strengthen sponsor relationships, and deliver measurable results.
Across the UK, many clinical teams are increasingly enthusiastic about entering commercial research but often lack a clear starting point.
They want to contribute to advancing science and improving patient access — yet navigating feasibility, governance, and sponsor engagement can feel complex and opaque.
At the same time, the UK faces a capacity challenge: despite strong demand from sponsors, the number of well-trained and commercially active research sites has plateaued.
By supporting new entrants and strengthening existing sites, ESMN Horizon is helping to expand national site capacity, accelerate study delivery, and enable more patients to participate in cutting-edge trials closer to home.
UK Clinical Research Capacity Snapshot
• Over 50% of GP practices express interest in commercial research, yet fewer than 10% are active participants.
• Sponsors report delays of 4–6 months in study start-up due to limited site availability.
• Increasing the pool of capable, research-ready sites could double patient access to commercial trials within five years.
(Sources: NIHR Site Alliance, ABPI, and independent industry reports.)

Operational Complexity: Navigating governance, compliance, and contracting can overwhelm clinical teams and delay study start-up.
Limited Capacity: Many sites lack the time, systems, or expertise to pursue and deliver more studies.
Unclear Commercial Strategy: Research capability often exists without a defined pathway to generate sustainable revenue or long-term partnerships.

End-to-End Readiness: We establish compliant frameworks covering SOPs, governance, and team capability — laying the foundation for commercial success.
Strategic Growth Planning: We help sites define their business model, engage sponsors proactively, and expand their commercial portfolio.
Embedded Partnership: Through mentorship, advisory retainers, and business development support, we strengthen delivery capacity and drive long-term financial sustainability.
We offer tailored engagement models designed to meet each site’s stage of maturity — from first-time entrants to established research networks seeking sustainable growth.
A structured programme to build compliance, SOPs, governance, and research capability — turning early interest into operational readiness.
We help practices and clinics develop the quality systems, infrastructure, and confidence needed to engage directly with sponsors and CROs.
For established or newly active sites, this service focuses on strengthening commercial performance and expanding study opportunities.
We help identify the right sponsors, improve feasibility response rates, and position your site competitively for inclusion in global trials.
Our support includes business development coaching, study-pipeline planning, and sponsor relationship management — ensuring your team stays commercially proactive, not reactive.
Continuous access to strategic, operational, and commercial guidance tailored to your site’s evolving goals.
In addition to governance and feasibility management, our team provides hands-on business development and sales enablement — from pipeline tracking and bid submissions to sponsor introductions and follow-up support.
We act as your long-term growth partner, ensuring momentum is maintained and new commercial opportunities are consistently converted into revenue.

Client: Large GP practice (newly research-active)
Challenge: Slow feasibility responses, missed PSVs, and limited commercial acumen.
Intervention: Commercial Research Manager-as-a-Service (RMaS) for feasibility tracking, PSV scheduling, and bid management.
Outcome: Turnaround time reduced from 10 days to 48 hours, win-rate up 60%, and clinical staff time protected.

Client: Research-active Primary Care Network (PCN)
Challenge: Eligible patients not matched or converted efficiently.
Intervention: Recruitment Performance Framework — daily screening reports, dashboards, and investigator engagement routines.
Outcome: Recruitment doubled within six months, screen failures reduced by 25%, and the site invited to participate in two additional Phase III trials.

Client: Independent GP practice (new to research)
Challenge: Reliant on NHS/QOF income with no commercial research pipeline.
Intervention: Readiness Accelerator programme with NCVR support, contract development, and targeted sponsor introductions.
Outcome: Three commercial studies secured in Year 1, generating £180,000+ in new annual revenue. ROI achieved after two studies.
Whether you’re preparing to enter clinical research or ready to expand your commercial portfolio, we can help you build a roadmap for growth.
Copyright © 2025 esmnhorizon.com - All Rights Reserved.